Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Drug Benefit Reg Coming In Early Summer, CMS Says

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS faces massive task in setting up program in time for Jan. 1, 2006 start date, and will be asking for help.

You may also be interested in...



Medicare Rx Card Pricing Complexity Is Learning Experience For CMS, Consultant Says

CMS will become more “savvy” in comparing drugs by the time its Part D regulations are drafted, Health Strategies Consultancy’s Mendelson says. Medco settlement agreement will also influence regs, he says.

Medicare Rx Card Pricing Complexity Is Learning Experience For CMS, Consultant Says

CMS will become more “savvy” in comparing drugs by the time its Part D regulations are drafted, Health Strategies Consultancy’s Mendelson says. Medco settlement agreement will also influence regs, he says.

Medicare Rx Drug Benefit Hearing To Include MedPAC Members

The Senate Governmental Affairs/Government Management Oversight Subcommittee will hear testimony from former MedPAC Chair Wilensky and current member DeParle.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel